JPRN-UMIN000005319已完成未知
Phase II clinical trial of immunotherapy with WT1 peptide vaccination for pediatric hematological malignancies after allogeneic stem cell transplantation. - Phase II clinical trial of immunotherapy with WT1 peptide vaccination for pediatric hematological malignancies after allogeneic stem cell transplantation.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe complications.
研究者
相似试验
已完成
不适用
Phase I clinical trial of immunotherapy with WT1 peptide vaccine for hematological malignancies after stem cell transplantatioAcute myeloid or lymphoid leukemia malignant lymphoma multiple myelomaJPRN-UMIN000004753Osaka University6
已完成
1 期
A phase I/II study of a WT1-W10 immunotherapy against high-risk MDS and MDS overt AML.High-risk MDS and MDS overt AMJPRN-UMIN000026023Department of Hematology and respiratory Medicine, School of Medicine, Kochi University60
已完成
1 期
A pilot trial of immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.Osteosarcoma Soft tissue sarcoma neuroblastoma Pediatric bone, soft tissue sarcoma at high risk of recurrence.JPRN-UMIN000005312Osaka Universty22
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50
已完成
不适用
Phase I/II clinical trial of WT1 peptide vaccine for the children with malignanciesJPRN-UMIN000002990Osaka Medical Center and Research Institute for Maternal and Child Health20